Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Immunome Inc (NQ: IMNM )

9.560 -0.340 (-3.43%)
Streaming Delayed Price Updated: 2:11 PM EST, Nov 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Immunome Inc

< Previous 1 2 3 4 5 6 Next >
62 Biggest Movers From Yesterday
Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares surged 208% to settle at $10.04 on Tuesday as the company said it received FDA breakthrough device designation for the treatment... 
Via Benzinga
Exposures Product Safety
Mid-Afternoon Market Update: Dow Jumps Over 600 Points; NeuroMetrix Shares Spike Higher
Toward the end of trading Tuesday, the Dow traded up 1.83% to 34,583.56 while the NASDAQ rose 1.74% to 14,523.41. The S&P also rose, gaining 1.70% to 4,330.82. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Immunome's Stock Is Soaring Today
Immunome Inc (NASDAQ:IMNM) is surging Tuesday morning afte... 
Via Benzinga
Thinking About Buying Stock In Immunome, Axsome Or Etsy?
Immunome Inc (NASDAQ:IMNM) shares are trading higher by 9.25% by $32.28 after the ... 
Via Benzinga
Dow Rises 500 Points as Rally Gains Momentum
Stocks are on a tear midday, as investors shake off delta variant fears and buy the dip in the wake of yesterday's selloff. 
Via Talk Markets
Topics Stocks
Exposures US Equities
34 Stocks Moving In Tuesday's Mid-Day Session
Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) shares climbed 50.9% to $4.2550. NeuroMetrix, Inc. (NASDAQ: NURO) gained 37.4% to $4.4750 as the company said it received FDA... 
Via Benzinga
IMNM Stock: The Covid Treatment News That Has Immunome Soaring Today
IMNM stock is having a great day today. The company is preparing to move forward with expedited testing for its delta variant treatment. 
Via InvestorPlace
Exposures COVID-19
Mid-Morning Market Update: Markets Open Higher; Philip Morris Posts Mixed Q2 Results
Following the market opening Tuesday, the Dow traded up 1.32% to 34,409.28 while the NASDAQ rose 0.48% to 14,343.85. The S&P also rose, gaining 0.91% to 4,297.39. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
Immunome Stock Jumps As COVID-19 Antibody Shows Preclinical Neutralizing Activity Against Delta Variant
Immunome Inc (NASDAQ: IMNM) has announced that its three-antibody cocktail (IMM-BCP-01) has demonstrated potent neutralizing activity against COVI-19 Delta variant... 
Via Benzinga
Exposures COVID-19
Immunome Antibody Cocktail (IMM-BCP-01) Neutralizes the SARS-CoV-2 Delta Variant in Pre-clinical Testing
From Immunome, Inc.
Via Business Wire
Immunome to Present at the Ladenburg Thalmann 2021 Healthcare Conference
From Immunome, Inc.
Via Business Wire
The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 19) Cytokinetics, Incorporated... 
Via Benzinga
Immunome Appoints Andrew Badley, M.D., to COVID-19 Advisory Board
From Immunome, Inc.
Via Business Wire
Immunome Appoints Franklyn G. Prendergast, M.D., Ph.D., to Board of Directors
From Immunome, Inc.
Via Business Wire
Immunome to Present at the Jefferies Virtual Healthcare Conference
From Immunome, Inc.
Via Business Wire
Immunome Secures Additional $4.3M Funding From DoD To Develop COVID-19 Antibody Cocktail
Immunome Inc (NASDAQ: IMNM) has secured additional funding of $4.3 million from the Department of Defense (DoD) for the development of an antibody cocktail (IMM-... 
Via Benzinga
Exposures COVID-19
60 Biggest Movers From Yesterday
Gainers Vertex Energy, Inc. (NASDAQ: VTNR) shares climbed 124.2% to settle at $3.99 on Thursday after the company announced plans to acquire a Alabama refinery and related... 
Via Benzinga
Immunome Announces Additional $4.3 Million Award by DOD following Positive Preclinical Testing Results on COVID-19 Variants of Concern
From Immunome, Inc.
Via Business Wire
Immunome Reports First Quarter 2021 Financial Results
From Immunome, Inc.
Via Business Wire
Immunome Raises $27M Via Private Equity Placement At 9%
In addition to encouraging preclinical data from the COVID-19 antibody cocktail announced today, Immunome Inc (NASDAQ: IMNM) has entered into a... 
Via Benzinga
Exposures COVID-19
Immunome's Stock Jumps On Its Antibody Cocktail Neutralizing Multiple COVID-19 Variants In Animal Studies
Immunome Inc (NASDAQ: IMNM) has announced antibody selection for its IMM-BCP-01 antibody cocktail and shared preclinical data showing that IMM-BCP-01 is... 
Via Benzinga
Exposures COVID-19
Immunome SARS-CoV-2 Antibody Cocktail Neutralizes UK, South Africa, Brazil and California Variants in Preclinical Testing; Progressing Towards IND Filing
From Immunome, Inc.
Via Business Wire
Immunome Announces $27 Million Private Placement
From Immunome, Inc.
Via Business Wire
Immunome Appoints Corleen Roche as Chief Financial Officer
From Immunome
Via Business Wire
55 Biggest Movers From Yesterday
Gainers Marlin Business Services Corp. (NASDAQ: MRLN) shares surged 50.7% to close at $21.46 on Monday after the company enters into a definitive agreement to be acquired by... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS